Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alfredo Fusco

Showing results (131-140 of 281) with videos related to

Pageof 29
Sort By:
Oncology Letters|August 16, 2013
DNA methylation state of the galectin-3 gene represents a potential new marker of thyroid malignancySimona Keller, Tiziana Angrisano, Ermanno Florio, et al.
The Journal of Clinical Endocrinology and Metabolism|September 30, 2011
miR-191 down-regulation plays a role in thyroid follicular tumors through CDK6 targetingMarianna Colamaio, Eleonora Borbone, Lucia Russo, et al.
The Biochemical Journal|February 17, 2005
High-mobility-group A1 (HMGA1) proteins down-regulate the expression of the recombination activating gene 2 (RAG2)Sabrina Battista, Monica Fedele, Josefina Martinez Hoyos, et al.
Oncotarget|May 17, 2014
HMGA1 silencing restores normal stem cell characteristics in colon cancer stem cells by increasing p53 levelsFrancesca Puca, Marianna Colamaio, Antonella Federico, et al.
Cancer Research|February 19, 2009
The beta-catenin axis integrates multiple signals downstream from RET/papillary thyroid carcinoma leading to cell proliferationMaria Domenica Castellone, Valentina De Falco, Deva Magendra Rao, et al.
Frontiers in Medicine|September 1, 2015
Deregulation of miR-183 and KIAA0101 in Aggressive and Malignant Pituitary TumorsMagali Roche, Anne Wierinckx, Séverine Croze, et al.
The American Journal of Pathology|March 4, 2005
Complex regulation of the cyclin-dependent kinase inhibitor p27kip1 in thyroid cancer cells by the PI3K/AKT pathway: regulation of p27kip1 expression and localizationMaria Letizia Motti, Daniela Califano, Giancarlo Troncone, et al.
Cell Cycle (Georgetown, Tex.)|January 2, 2024
Drug-induced inhibition of HMGA and EZH2 activity as a possible therapy for anaplastic thyroid carcinomaMarco De Martino, Simona Pellecchia, Myriam Decaussin-Petrucci, et al.
Cancer Research|November 13, 2003
Suppression of HMGA2 protein synthesis could be a tool for the therapy of well differentiated liposarcomas overexpressing HMGA2Francesca Pentimalli, Monica Dentice, Monica Fedele, et al.
Oncogene|September 21, 2004
The tyrosine phosphatase PTPRJ/DEP-1 genotype affects thyroid carcinogenesisRodolfo Iuliano, Ilaria Le Pera, Carmela Cristofaro, et al.
Pageof 29

Showing results (131-140 of 281) with videos related to

Sort By:
Pageof 29
Oncology Letters|August 16, 2013
DNA methylation state of the galectin-3 gene represents a potential new marker of thyroid malignancySimona Keller, Tiziana Angrisano, Ermanno Florio, et al.
The Journal of Clinical Endocrinology and Metabolism|September 30, 2011
miR-191 down-regulation plays a role in thyroid follicular tumors through CDK6 targetingMarianna Colamaio, Eleonora Borbone, Lucia Russo, et al.
The Biochemical Journal|February 17, 2005
High-mobility-group A1 (HMGA1) proteins down-regulate the expression of the recombination activating gene 2 (RAG2)Sabrina Battista, Monica Fedele, Josefina Martinez Hoyos, et al.
Oncotarget|May 17, 2014
HMGA1 silencing restores normal stem cell characteristics in colon cancer stem cells by increasing p53 levelsFrancesca Puca, Marianna Colamaio, Antonella Federico, et al.
Cancer Research|February 19, 2009
The beta-catenin axis integrates multiple signals downstream from RET/papillary thyroid carcinoma leading to cell proliferationMaria Domenica Castellone, Valentina De Falco, Deva Magendra Rao, et al.
Frontiers in Medicine|September 1, 2015
Deregulation of miR-183 and KIAA0101 in Aggressive and Malignant Pituitary TumorsMagali Roche, Anne Wierinckx, Séverine Croze, et al.
The American Journal of Pathology|March 4, 2005
Complex regulation of the cyclin-dependent kinase inhibitor p27kip1 in thyroid cancer cells by the PI3K/AKT pathway: regulation of p27kip1 expression and localizationMaria Letizia Motti, Daniela Califano, Giancarlo Troncone, et al.
Cell Cycle (Georgetown, Tex.)|January 2, 2024
Drug-induced inhibition of HMGA and EZH2 activity as a possible therapy for anaplastic thyroid carcinomaMarco De Martino, Simona Pellecchia, Myriam Decaussin-Petrucci, et al.
Cancer Research|November 13, 2003
Suppression of HMGA2 protein synthesis could be a tool for the therapy of well differentiated liposarcomas overexpressing HMGA2Francesca Pentimalli, Monica Dentice, Monica Fedele, et al.
Oncogene|September 21, 2004
The tyrosine phosphatase PTPRJ/DEP-1 genotype affects thyroid carcinogenesisRodolfo Iuliano, Ilaria Le Pera, Carmela Cristofaro, et al.
Pageof 29